Efficacy of Moses Technology versus non-Moses Technology during retrograde intrarenal surgery: a randomized controlled trail

Efficacy of Moses Technology versus non-Moses Technology during retrograde intrarenal surgery: a randomized controlled trail - Moses comparative trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000053969

Enrollment

Registered

2024-07-01

Start date

2024-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney and ureteral stones

Interventions

Moses group 2 groups are randomized between Moses Technology mode and non-Moses mode (Short pulse mode) Non-Moses group (Short pulse group)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Performance status<1 Stone size in kidney and ureter (15mm< stone <30mm) Patient who hopes to use flexible ureteroscopy Patient who can understand the explanation to join this study

Exclusion criteria

Exclusion criteria: Patient with difficulty of communication Patient with anomaly genitourinary system Patient with pregnant Patients with a body mass index (BMI) greater than 45

Design outcomes

Primary

Measure	Time frame
Total operative time between Moses and non-Moses technology	—

Secondary

Measure	Time frame
Ureteroscopy time Stone free rate on postoperative 1mo Stone free rate on postoperative 3mo Total laser time (sec) Total laser energy (J) Laser ablation speed Laser ablation efficiency	—

Countries

Japan

Contacts

Public ContactTakaaki Inoue

Hara Genitourinary hospital Urology

inouetak@harahospital.jp+81783711203

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026